Cogent Biosciences, Inc.COGTNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank95
5Y CAGR+23.2%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+23.2%/yr
Long-term compound
Percentile
P95
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 256.26% |
| Q3 2025 | 95.09% |
| Q2 2025 | -29.92% |
| Q1 2025 | -16.70% |
| Q4 2024 | -18.77% |
| Q3 2024 | -24.05% |
| Q2 2024 | -15.58% |
| Q1 2024 | 49.87% |
| Q4 2023 | -15.44% |
| Q3 2023 | -24.58% |
| Q2 2023 | 47.47% |
| Q1 2023 | -12.88% |
| Q4 2022 | -12.94% |
| Q3 2022 | -35.56% |
| Q2 2022 | 55.27% |
| Q1 2022 | -14.82% |
| Q4 2021 | -1.22% |
| Q3 2021 | -10.59% |
| Q2 2021 | -14.85% |
| Q1 2021 | -71.00% |
| Q4 2020 | 90.31% |
| Q3 2020 | 376.24% |
| Q2 2020 | -27.48% |
| Q1 2020 | -17.67% |
| Q4 2019 | 10.96% |
| Q3 2019 | -28.37% |
| Q2 2019 | -20.46% |
| Q1 2019 | -18.72% |
| Q4 2018 | -10.81% |
| Q3 2018 | -14.06% |
| Q2 2018 | 334.86% |
| Q1 2018 | -49.96% |
| Q4 2017 | -17.91% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q3 2015 | 0.00% |